Brookfield Corp’s GE HealthCare GEHC Stock Holding History

Brookfield Corp’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-94,397	Closed	-$7.67M	–	279
2023 Q2	$7.67M	Buy	+94,397	New	+$7.53M	0.03%	196

Other funds holding GEHC

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Brookfield Corp's GEHC Position: Q3 2023 in Review

Brookfield Corp sold out of GE HealthCare (GEHC) in Q3 2023, closing a stake of 94,397 shares — an estimated $7.67M sold.

Brookfield Corp first reported a position in GEHC in Q2 2023 and held it in 1 quarter. The position peaked at $7.67M in Q2 2023. 1,106 funds tracked by Wall St. Rank hold GEHC as of Q3 2023.

Brookfield Corp reported no remaining GE HealthCare position as of Q3 2023 after selling out during the quarter.
Brookfield Corp sold 94,397 GE HealthCare shares in Q3 2023, an estimated $7.67M.
Brookfield Corp first reported a position in GE HealthCare in Q2 2023 and held it in 1 quarter.
Brookfield Corp's GE HealthCare position peaked at $7.67M in Q2 2023.
1,106 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.